Facial neuromuscular junctions and brainstem nuclei are the target of tetanus neurotoxin in cephalic tetanus.
Neurological disorders
Neuromuscular disease
Neuroscience
Toxins/drugs/xenobiotics
Journal
JCI insight
ISSN: 2379-3708
Titre abrégé: JCI Insight
Pays: United States
ID NLM: 101676073
Informations de publication
Date de publication:
08 06 2023
08 06 2023
Historique:
received:
08
11
2022
accepted:
28
04
2023
medline:
9
6
2023
pubmed:
9
5
2023
entrez:
9
5
2023
Statut:
epublish
Résumé
Cephalic tetanus (CT) is a severe form of tetanus that follows head wounds and the intoxication of cranial nerves by tetanus neurotoxin (TeNT). Hallmarks of CT are cerebral palsy, which anticipates the spastic paralysis of tetanus, and rapid evolution of cardiorespiratory deficit even without generalized tetanus. How TeNT causes this unexpected flaccid paralysis, and how the canonical spasticity then rapidly evolves into cardiorespiratory defects, remain unresolved aspects of CT pathophysiology. Using electrophysiology and immunohistochemistry, we demonstrate that TeNT cleaves its substrate vesicle-associated membrane protein within facial neuromuscular junctions and causes a botulism-like paralysis overshadowing tetanus spasticity. Meanwhile, TeNT spreads among brainstem neuronal nuclei and, as shown by an assay measuring the ventilation ability of CT mice, harms essential functions like respiration. A partial axotomy of the facial nerve revealed a potentially new ability of TeNT to undergo intra-brainstem diffusion, which allows the toxin to spread to brainstem nuclei devoid of direct peripheral efferents. This mechanism is likely to be involved in the transition from local to generalized tetanus. Overall, the present findings suggest that patients with idiopathic facial nerve palsy should be immediately considered for CT and treated with antisera to block the potential progression to a life-threatening form of tetanus.
Identifiants
pubmed: 37159261
pii: 166978
doi: 10.1172/jci.insight.166978
pmc: PMC10393225
doi:
pii:
Substances chimiques
tetanospasmin
11032-48-7
Botulinum Toxins
EC 3.4.24.69
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nat Rev Microbiol. 2010 Sep;8(9):645-55
pubmed: 20706281
Cell Microbiol. 2019 Nov;21(11):e13037
pubmed: 31050145
Methods Enzymol. 1995;248:643-52
pubmed: 7674951
Nature. 1955 Jan 15;175(4446):120-1
pubmed: 13235820
J Neurol Neurosurg Psychiatry. 1983 Sep;46(9):862-6
pubmed: 6311990
Exp Brain Res. 1987;65(2):385-98
pubmed: 3556466
Pract Neurol. 2014 Feb;14(1):39-41
pubmed: 24052566
Toxins (Basel). 2015 Dec 08;7(12):5322-36
pubmed: 26670253
J Neurol Neurosurg Psychiatry. 1973 Apr;36(2):296-301
pubmed: 4708462
Lancet. 2019 Apr 20;393(10181):1657-1668
pubmed: 30935736
BMJ. 2003 Jan 18;326(7381):117-8
pubmed: 12531822
J Neurochem. 2021 Sep;158(6):1244-1253
pubmed: 33629408
Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31
pubmed: 24467647
Neuron. 2010 Feb 11;65(3):422-35
pubmed: 20159454
Elife. 2016 Feb 15;5:
pubmed: 26880559
Pharmacol Rev. 2017 Apr;69(2):200-235
pubmed: 28356439
MethodsX. 2018 Mar 30;5:283-298
pubmed: 30042925
Case Rep Med. 2009;2009:548343
pubmed: 19710932
Clin Transl Med. 2022 Jan;12(1):e651
pubmed: 35075797
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13310-5
pubmed: 8917587
Hypertension. 1988 Jun;11(6 Pt 2):602-7
pubmed: 2899058
Am J Emerg Med. 1988 Mar;6(2):128-30
pubmed: 3281682
Ann Rehabil Med. 2012 Feb;36(1):167-70
pubmed: 22506253
Philos Trans R Soc Lond B Biol Sci. 2009 Sep 12;364(1529):2577-87
pubmed: 19651658
Arch Toxicol. 2022 Jun;96(6):1521-1539
pubmed: 35333944
Nature. 1993 Aug 12;364(6438):581-2
pubmed: 8350916
Toxins (Basel). 2019 Nov 22;11(12):
pubmed: 31771110
PLoS Pathog. 2017 Aug 11;13(8):e1006567
pubmed: 28800600
Biochim Biophys Acta. 2016 Mar;1858(3):467-74
pubmed: 26307528
Brain Behav Evol. 1984;24(2-3):144-51
pubmed: 6466963
Int J Mol Sci. 2022 Apr 14;23(8):
pubmed: 35457172
Neurology. 2019 Nov 19;93(21):e1995-e1996
pubmed: 31740518
Nature. 1992 Oct 29;359(6398):832-5
pubmed: 1331807
BMJ Case Rep. 2017 Jan 20;2017:
pubmed: 28108438
Lancet. 2015 Jan 24;385(9965):362-70
pubmed: 25149223
J Neurosci. 2011 Nov 2;31(44):15650-9
pubmed: 22049408
Br Med Bull. 2015;116:69-77
pubmed: 26598719
Wkly Epidemiol Rec. ;92(6):53-76
pubmed: 28185446
J Physiol. 1957 Mar 11;135(3):655-72
pubmed: 13417129
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):406-411
pubmed: 35298457
Brain Res. 1977 Feb 25;122(3):459-74
pubmed: 66083
J Clin Invest. 2021 Nov 15;131(22):
pubmed: 34618682
J Neurosci. 2008 Apr 2;28(14):3689-96
pubmed: 18385327
J Pathol Bacteriol. 1950 Oct;62(4):569-83
pubmed: 14804236
Nat Rev Microbiol. 2014 Aug;12(8):535-49
pubmed: 24975322